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ABSTRACT
Neuroglobin (NGB) is predominantly expressed in
the brain and retina. Studies suggest that NGB exerts
protective effects to neuronal cells and is implicated
in reducing the severity of stroke and Alzheimer’s
disease. However, little is known about the mecha-
nisms which regulate the cell type-specific expres-
sion of the gene. In this study, we hypothesized that
distal regulatory elements (DREs) are involved in op-
timal expression of the NGB gene. By chromosome
conformation capture we identified two novel DREs
located −70 kb upstream and +100 kb downstream
from the NGB gene. ENCODE database showed the
presence of DNaseI hypersensitive and transcription
factors binding sites in these regions. Further anal-
yses using luciferase reporters and chromatin im-
munoprecipitation suggested that the −70 kb region
upstream of the NGB gene contained a neuronal-
specific enhancer and GATA transcription factor
binding sites. Knockdown of GATA-2 caused NGB
expression to drop dramatically, indicating GATA-2
as an essential transcription factor for the activation
of NGB expression. The crucial role of the DRE in
NGB expression activation was further confirmed by
the drop in NGB level after CRISPR-mediated dele-
tion of the DRE. Taken together, we show that the
NGB gene is regulated by a cell type-specific loop
formed between its promoter and the novel DRE.
INTRODUCTION
Gene transcription is a complex process involving the or-
chestration of diverse elements such as promoters, en-
hancers and insulators ensuring that gene expression is un-
der accurate control. A recent genome-wide study showed
that distal enhancers play more important roles than proxi-
mal promoters in controlling cell type-specific gene expres-
sion (1). Mutations in these distal elements may cause dis-
eases, as seen in the case of -thalassaemia. Expression of
an intact -globin (HBB) gene may be inactivated by dele-
tion of the locus control region (LCR) (2). The LCR is a col-
lection of DREs that control cell type-specific and temporal
expression of the genes in the HBB gene cluster (3). Iden-
tification of such gene regulatory elements is therefore im-
portant for the understanding of gene transcriptional regu-
lation and disease pathology.
Active regulatory elements are often associated with
DNaseI hypersensitive sites (DHS), which are enriched by
marks of open chromatin structure and locus accessibility
such as histone 3 lysine 4 mono-methylation (H3K4me1)
and H3K27 acetylation (H3K27Ac), and contain clusters
of transcription factor binding sites (TFBS) (4,5). These
features provide clues for identifying regulatory elements,
which can be located up to megabases away from the target
gene (6,7), thus making their discovery challenging.
Based on the widely accepted chromatin looping model,
where a loop is formed by the DNA segment between a
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distal enhancer and its target gene promoter thus bringing
the two elements in spatial proximity (8,9), such enhancer-
promoter interactions can be revealed by chromosome con-
formation capture (3C) (10). 3C provides a powerful tool
to search for regulatory elements by identifying distal re-
gions that interact with the gene of interest. This has been
demonstrated successfully byGhedof et al. in searching reg-
ulatory elements of theCFTR gene (11). Here, we use a sim-
ilar approach to identify distal regulatory elements of the
human neuroglobin (NGB) gene. To date, no regulatory ele-
ment of the humanNGB gene is known except for the recent
characterization of the promoter (12). It is thus relevant to
identify the regulatory elements because mutations ofNGB
have been associated with higher risk of Alzheimer’s disease
(AD) (13). Potentially the risk is also associated with muta-
tions in the regulatory elements of NGB gene. Understand-
ingNGB gene regulation may provide (i) a novel diagnostic
approach for the risk of AD on individuals and (ii) a new
target of therapy or preventive measures against the disease.
NGB is a neuro-protective protein which may protect
neuronal cells from hypoxia, ischemia, stroke, oxidative
stress, mechanical injuries and AD (14–19). It is predomi-
nantly expressed in neurons (20) and some endocrine tissues
(21), but the highest expression level is found in retina (22).
Besides this spatial specificity, expression of the NGB gene
also shows temporal changes in human and rodent dur-
ing development and aging. In the neonatal mouse brain,
NGB level increases throughout development and reaches
its maximum at day 14 after birth (23), whilst in the adult
rat brain NGB level declines with age (24). The latter find-
ing is in line with a postmortem study performed on adult
human brain in whichNGB level was found to be negatively
correlated with age (13). Interestingly, the same study found
that two AD risk factors, age and female sex, were associ-
ated with lower NGB levels. However, the mechanisms of
spatial and temporal transcriptional regulation of theNGB
gene are unknown.
We previously identified the binding sites of Sp1 and
Sp3 on two functional GC-boxes in the promoter region
of the NGB gene and showed that DNA methylation was
associated with cell type-specific expression (12). Others
subsequently reported the presence of binding sites of the
early growth response protein 1 (Egr1), nuclear factor -
light-chain-enhancer of activated B cells (Nf-b) (25), cyclic
AMP responsive element binding protein (CREB) (26)
and hypoxia-inducible factor-1 (Hif-1) on the promoter of
the mouse Ngb gene (27). However, these ubiquitous and
stimuli-activated TFs may not explain the cell type-specific
expression of NGB in full. We hypothesized that there are
DREs governing the binding of these factors or cooperating
with them to control NGB gene expression.
In this study, a combination of the 3C technique and in
silico analysis was employed to locate potential DREs of the
human NGB gene. A 300 kb region covering the NGB gene
was analyzed in both neuronal and non-neuronal cell lines.
Two novel regions that interact with the NGB gene were lo-
cated at −70 kb upstream and at +100 kb downstream. In-
terestingly, the interaction frequency between the upstream
region and NGB is significantly higher in a neuronal cell
line whilst the downstream element showed similar inter-
action frequencies across cell lines. In addition, a segment
of the upstream region showed cell-type specific activating
function on theNGB promoter in luciferase reporter assays.
CRISPR-mediated deletion further supported the notion
that this segment is a bona fide distal regulatory element for
the NGB gene and that it may be a key regulator for the
spatial and temporal expression of the NGB gene.
MATERIALS AND METHODS
Cell culture
Human neuroblastoma SH-SY5Y cells, cervical adenocar-
cinoma HeLa cells, erythromyeloblastoid leukemia K562
cells and human embryonic kidney cell HEK 293T cells
were purchased from American Type Culture Collection
(ATCC). These cell lines were cultured in 1:1 mixture of
minimum essential medium (MEM) and Ham’s F12 nutri-
ent mixture (for SH-SY5Y cells), Dulbecco’s modified Ea-
gle medium (DMEM) (for HeLa and HEK293T cells) and
Roswell ParkMemorial Institute (RPMI) 1640medium (for
K562 cells) respectively. All the media (Gibco) were sup-
plemented with 10% fetal bovine serum (Hyclone) and 1%
penicillin–streptomycin (Invitrogen).
qRT-PCR
RNA was extracted from the cultured cell by TRIzol (In-
vitrogen) following manufacturer’s standard procedure. Ex-
tracted RNA was converted to cDNA using ThermoScript
Reverse Transcriptase (Invitrogen) and PCRwas performed
with RT2 SYBR Green qPCR Master Mixes (SABio-
sciences). The mRNA levels were determined by two in-
dependent experiments. Sequences of the primers used are
shown in Supplementary Table S1.
Chromosome conformation capture (3C) analysis
3C was performed by following a previously described pro-
tocol using EcoRI digestion (28). To generate a control li-
brary, bacterial artificial chromosomes (BAC) RP11-463C8
and RP11-493G17 clones were purchased from Children’s
Hospital Oakland Research Institute (CHORI). The two
BAC clones carried sequences overlapping the humanNGB
gene region. The library was made by mixing equimolar
amount of each BAC clone and used to normalize for differ-
ences in primer efficiency (29). For comparison between cell
lines, each interaction frequency detected was also normal-
ized to the interaction between exons 2 and 8 of the human
-actin (ACTA2) gene (30).
Primers were designed on the EcoRI fragment contain-
ing the NGB gene, the anchor fragment, and paired with
primers in the other fragments surrounding the 300kb re-
gion of the NGB gene. Sequences of the primers used are
listed in Supplementary Table S1. The PCR was performed
in a touchdown manner (31).
In silico analysis for DHS and transcription factor binding
sites mapping
Information on DNaseI hypersensitive sites (DHS)
and ChIP-sequencing of transcription factors bind-
ing sites as well as histone modifications was obtained
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from the ENCODE database on the UCSC genome
browser (http://genome.ucsc.edu/, Assembly February
2009 (GRCh37/hg19)) (32).
Luciferase reporter constructs
All constructs were derived from a pGL3-basic vector with
the 1051 bp NGB promoter inserted between the HindIII
and MluI sites (named p(−745/+306)) (12). From the 3C
and in silico analysis results, two regions were selected to
be inserted into the vector for further investigation. The
fragments of genomic coordinates 77808992–77809573 and
77636994–77636265 on chromosome 14 (hg19) were sub-
cloned into the p(−745/+306) promoter-only construct at
theMluI site upstream of the promoter or between the SacI
and BamHI sites downstream of the luciferase (LUC) gene,
in either orientation. The orientation of inserts was con-
firmed by DNA sequencing.
Transfection and luciferase assay
SH-SY5YandHeLa cells were seeded at densities of 3× 104
and 1 × 104 per well respectively in 96-well plates with 100
l corresponding mediumwithout antibiotics. Transfection
mediumwas prepared bymixing 60 ng of the construct, 2 ng
pRL-CMVand 0.5l Lipofectamine (Invitrogen) in serum-
free medium. After 30 min incubation at room temperature,
themixturewas diluted 6-foldwith serum-freemedium. The
medium in the 96-well plate was replaced by the diluted
transfectionmediumand incubated for 4 h in humidified 5%
CO2 incubator. Then medium with 20% FBS was added to
make the final FBS content in the medium 10%. The trans-
fected cells were further incubated for 48 h.
The Dual-Luciferase Reporter Assay System (Promega)
was used to assess the luciferase activities of the transfected
cells according to the manufacturer’s instructions.
Chromatin immunoprecipitation (ChIP)
ChIP was performed as previously described (33). The an-
tibodies used for the ChIP experiment were anti-GATA-2
(sc-9008X, Santa Cruz) and anti-GATA-3 (sc-268X, Santa
Cruz) and non-specific rabbit IgG (sc-2027X, Santa Cruz).
Primers used for the experiment are listed in Supplementary
Table S1.
GATA-2 and GATA-3 knockdown cell generation
shRNA plasmids pLKO.1 control vector (SHC002), and
shRNA targeting GATA-2 (pLKO-G2a and pLKO-G2b)
andGATA-3 (pLKO-G3a and pLKO-G3b) were purchased
from Sigma (the sequences of the shRNA inserts are shown
in Supplementary Table S1). Lentiviral particles were pro-
duced by co-transfecting HEK 293T cells with the shRNA
plasmids, packaging plasmid psPAX2 and envelop plasmid
pMD2.G by using polyethylenimine (Sigma). DMEM was
replaced by MEM:F12 mixture one day after transfection
to collect the virus in the appropriate medium for infection.
MEM:F12 containing the virus was then filtered and mixed
with polybrene (Sigma). SH-SY5Y cells were infected with
the virus for 24 h and then cultured in normal MEM:F12
for 3 days prior to selection with puromycin (1 g/ml).
Western blotting
Protein of normal or infected SH-SY5Y cells was extracted
using radio-immunoprecipitation assay (RIPA) buffer (0.15
M NaCl, 1% NP40, 0.01 M deoxycholate, 0.1% SDS,
0.05 M Tris–HCl pH 8.0) with protease inhibitor cock-
tail (Roche). 20 g of the total protein was separated by
SDS-PAGE (polyacrylamide gel electrophoresis) with 12%
polyacrylamide gel and transferred to polyvinylidene diflu-
oride membranes. The proteins were probed by antibodies
for GATA-2 (sc-9008, Santa Cruz), GATA-3 (sc-268, Santa
Cruz), -actin (sc-69879, Santa Cruz) and NGB (Absea),
and then detected by ECL Prime Western Blotting Detec-
tion Reagent (GE Healthcare).
Clustered regularly-interspaced short palindromic repeats
(CRISPR)-Cas9 mediated genome editing
The CRISPR/Cas9 mediated genomic deletion procedure
described by Bauer et al. (34) was modified to delete the pu-
tative regulatory Element I detected by 3C. Instead of elec-
troporation, we performed transfection by using Lipofec-
tamine 3000 (Thermo Fisher Scientific). Two pX330 vec-
tors (Addgene) which express Cas9 and the desired gR-
NAs, togetherwith the puromycin resistance vectorwere co-
transfected into SH-SY5Y cells. The gRNA sequences are
displayed in Supplementary Table S1. gRNA-A (chr14:77
808 950–77 808 972) and gRNA-B (chr14:77 808 916–77
808 938) were paired with gRNA-C (chr14:77 809 411–
77 809 433) to make clones with different genomic dele-
tions. Transfected cells were incubated in medium with 1
g/ml puromycin for selection. In order to reduce hetero-
geneity of the culture, limiting dilution was performed on
the puromycin-selected cells. Cultures showing Element I
deletion were selected for analysis.
RESULTS
Differential NGB expression levels in human cell lines
To confirm the tissue-specific expression of NGB, mRNA
levels of three different human cell lines were quantified by
qRT-PCR. The results showed that NGB expression in the
neuroblastoma cell line SH-SY5Y was 300- and 240-fold
higher than that in non-neuronal cells HeLa and K562, re-
spectively (Figure 1A). Thus, NGB is highly expressed in
SH-SY5Y neuronal cells but barely expressed in HeLa and
K562 cells.
Identification of distal regions interacting with NGB gene
A 300kb region covering the NGB gene was analyzed in
search for elements that physically interacted with the pro-
moter of the NGB gene. A preliminary screening was done
to select fragments within the region for 3C analysis. Eigh-
teen fragments with active marks such as DNaseI hypersen-
sitivity, TF binding and hyperacetylated H3 identified with
the UCSC genome browser (32) (data not shown) were se-
lected and primers were designed close to the EcoRI restric-
tion sites of these fragments.
From the 3C results, two peaks of frequent proximity
with the anchor fragment were observed in SH-SY5Y cells,
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Figure 1. (A) NGB mRNA level in three human cell lines quantified by qRT-PCR. The NGB level in SH-SY5Y cells was 300-fold of that in HeLa cells
and 240-fold of that in K562 cells. ***P < 0.001 compared to HeLa (N = 3, mean ± SEM). (B and C) The 3C profiles in SH-SY5Y and HeLa cells of the
300 kb region surrounding the NGB gene. The anchor fragments are indicated by the dashed lines. Approximate positions and direction of transcription
of genes, and EcoRI cutting sites within the area are displayed at the top. Significant differences between cell types were detected by Student’s t test (*P <
0.05) (N = 3, mean ± SEM).
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while only one peak was observed in HeLa and K562 cells
(Figure 1B). The peak presented in SH-SY5Y cells only was
located at −70 kb upstream of the NGB gene transcription
start site (TSS) and another peak was located at +100 kb
downstream of the TSS. The interaction frequency between
the−70 kb fragment and the anchor fragment in SH-SY5Y
cells was about 2.5-fold higher than in HeLa cells. Similar
interaction frequencies were observed in all the three cell
lines at the +100kb downstream region of the NGB gene.
The −70 kb fragment is 3 kb in length spanning across
the exons 5 and 6, intron 5 and the 3′ flanking region of
transmembrane emp24 protein transport domain contain-
ing eight (TMED8) gene (chr14:77 806 771–77 809 773
(hg19)). The +100 kb fragment is a 4 kb segment located
at the 5′ flanking region of transmembrane protein 63C
(TMEM63C) gene (chr14:77 635 927–77 639 784 (hg19)).
3C analysis using the −70 kb upstream novel distal ele-
ment as the anchor point was conducted to confirm the spe-
cific interactions occurring in SH-SY5Y cells (Figure 1C).
The same set of fragments in the regionwas analyzed. In line
with the previous results, a local peak was observed at the
NGB gene-containing fragment in SH-SY5Y cells. In HeLa
cells, although the interaction frequency was relatively high
within the region, it was significantly lower and was about
half of that in SH-SY5Y cells. There was another peak lo-
cated at the promoter regions of the GSTZ and POMT2
genes. This may imply that regulatory elements contained
in the−70 kb fragment could interact and regulate promot-
ers within the region. However, we found that the interac-
tion frequencies were similar in the two cell lines tested. In
contrast, the interaction between the NGB gene containing
fragment and the −70 kb upstream fragment showed cell
type-specificity in SH-SY5Y cells. This suggests that the cell
type-specific expression regulation of NGB is controlled by
the element located at −70 kb fragment.
Mapping of potentially functional segments within the 3C
fragments by in silico analysis
The potential distal regulatory elements were subjected to
analysis using the UCSC genome browser (http://genome.
ucsc.edu/, Assembly Feb 2009 (GRCh37/hg19)) (32). The
results revealed the positions of the potentially active regu-
latory elements within the −70 kb and +100 kb fragments.
Interestingly, within the −70 kb fragment, in a ∼500 bp
region within intron 5 of the TMED8 gene, we found the
presence ofDHS, TFbinding, enrichment ofH3K4me1 and
H3K27Ac but the absence ofH3K4me3marks. This combi-
nation of features is characteristic of enhancer elements. Of
note, the DHS was found to be present in this region (Top
panel, Figure 2A) in HRPEpiC (a human retinal pigment
epithelial cell line) (35), NH-A, HA-h (human astrocyte cell
line), M059J (a glioblastoma cell line) (36) which all express
neuroglobin, and also in HeLa and K562 cells. Apparently
the locus contains DHS in multiple cell types, which is ac-
cessible for transcription factor binding.
ChIP-seq data showed that there are a number of TFs
binding at the ∼500 bp region in the −70 kb fragment.
These TFs are FOSL2, GATA-3, JunD and NFIC in SK-
N-SH cells (the parental cell line of SH-SY5Y), FOSL1,
GATA-2, Pol2-4H8, NR2F2, NRSF, TEAD4, c-Jun, JunD,
CoREST, MAZ, p300 and TAL1 in K562 cells, and c-Myc,
CoREST, JunDandMAZ inHeLa S3 cells (a clone ofHeLa
cells) (Middle panel, Figure 2A).
Around the same region, enrichment of H3K4me1 was
observed but H3K4me3 was absent in K562, HeLa and
NH-A cells (Bottom panel, Figure 2A). These data suggest
that the 500bp site is a potential active distal regulatory ele-
ment as predicted by the presence of TFbinding and histone
marks. This fragment was termed Element I.
The ENCODE database revealed that at the +100 kb re-
gion downstream of the NGB gene TSS, DHS were found
in HeLa and Medullo (a medulloblastoma cell line) cells at
different sites (Top panel, Figure 2B), but not in K562 cells.
However, ChIP-seq data showed that the presence of TFs
CBX3, TRIM28 and Z143 binding sites in K562 cells ap-
proximately at the position of the DHS found in Medullo
cells (lower panel, Figure 2B). The database showed no
TF binding on the fragment in HeLa and Medullo cells.
In all these three cell lines, neither H3K4me1, H3K4me3
nor H3K27Ac enrichment were observed (data not shown).
This fragment was termed Element II.
In conclusion, analysis of these regions revealed poten-
tially active regulatory elements within the −70 kb and
+100 kb fragments. Furthermore, ChIP-seq data showed
the presence of multiple TF binding sites in the −70 kb re-
gion. These elements thus served as the focus of our subse-
quent studies.
Activating functions of distal elements probed by luciferase
assays
Luciferase reporter construct assays encompassing the two
elements at −70 kb (Element I) and +100 kb (Element II)
of the NGB gene were employed to delineate the functions
of the two elements. These constructs harbor Element I or
II inserted into p(−745/+306) (see Materials and Meth-
ods section) at different positions and orientations and were
transfected into SH-SY5Y and HeLa cells.
Results displayed in Figure 2C show that Element I has
an activating function which is cell type-, position- and
orientation-dependent, while Element II has no significant
effect on luciferase activities (in Figure 2D).
In SH-SY5Y cells, when Element I was inserted up-
stream of the human NGB gene promoter, luciferase ac-
tivity increased about 6-fold compared to the promoter-
only construct. Interestingly, when Element I was inserted
downstream of the luciferase gene or flipped in the oppo-
site orientation, the increase of luciferase activity dropped
significantly to about 3.5-fold compared to the promoter-
only construct. Furthermore, when Element I was inserted
downstreamof the luciferase gene and in the opposite orien-
tation, there was no significant difference compared to the
promoter-only construct. In HeLa cells, all the constructs
showed no significant effects on the NGB promoter. Thus
we conclude that Element I harbors a cell type-specific en-
hancer function for the NGB gene.
Transcription factor binding on Element I detected by chro-
matin immunoprecipitation (ChIP)
To identify potential TFs which bind to Element I in a cell
type-specific manner, the sequence of Element I was ana-
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Figure 2. (A) Modified screen shot of UCSC genome browser page showing DHS and ChIP-seq data of the two EcoRI fragments interacting with the
NGB anchor fragment. The upstream fragment (chr14:77 806 771–77 809 773 (hg19)) contains Element I used for luciferase assays. (B) The downstream
fragment (chr14:77 635 927–77 639 784 (hg19)) contains Element II. The elements used for luciferase assays are outlined by rectangular boxes. (C and D)
Relative luciferase activities of the constructs in SH-SY5Y and HeLa cells. On the left, structures of the constructs used for luciferase assays are shown.
The white boxes represent Element I (C) and Element II (D) respectively. The arrows in the box indicate the orientation of the inserted element. All the data
are normalized to the promoter-only construct. ***P < 0.001 compared to promoter-only construct, #P < 0.05 between groups (N = 6, mean ± SEM).
lyzed using MatInspector (37). Among the potential TFs
listed, there were multiple predicted sites for GATA bind-
ing proteins (GATA) (the complete list of potential TFs
binding sites of Element I is shown in Supplementary Ta-
ble S2). Since GATA-2 and -3 have been reported to be in-
volved in neuronal development (38–40) and in activation
of distal enhancers (41–43), ChIP was employed to investi-
gate whether GATA-2 and/or GATA-3 were able to bind to
Element I in vivo as predicted in silico.
Enrichment of GATA-2 at Element I was confirmed.
The ChIP results showed that cell-type specific binding of
GATA-2 at Element I was comparable to that at the pro-
moter of neutral ceramidase (ASAH2) gene (Figure 3A).
They were respectively 4.8-fold and 5.7-fold increase com-
pared to the signal given by control immunoprecipitation
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Figure 3. GATA factors binding revealed by ChIP. The enrichments of the target proteins at specified sites are expressed relative to that of non-specific
immunoprecipitated (IP) DNA by rabbit IgG. The binding of GATA-2 (A) but not GATA-3 (B) was observed in SH-SY5Y cells. *P < 0.05, **P < 0.01
for comparing enrichment to the signal obtained with rabbit IgG IP (N = 5, mean ± SEM)
(IP) with rabbit IgG. The binding ofGATA-2 at theASAH2
gene in undifferentiated SH-SY5Y cells has been demon-
strated (44), thus ASAH2 served as the positive control for
GATA-2 binding in this experiment. The promoter region
of the ACTA2 gene where no GATA factor binding was
shown, served as the negative control of both GATA fac-
tors. In HeLa cells, the binding of GATA-2 at all the three
areas tested waw weak and showed no significant difference
with the non-specific signal.
GATA-3 binding was not detected at Element I in SH-
SY5Y and HeLa cells (Figure 3B). The signals were similar
to the non-specific signal. The experiment was validated by
the high enrichment of GATA-3 at the cyclin D1 gene pro-
moter in SH-SY5Y neuroblastoma cells (2.5-fold of non-
specific signal). Cyclin D1 was shown to be a downstream
target of GATA-3 and is abundantly expressed in neurob-
lastoma cells (45). Therefore, we concluded that Element I
is bound by GATA-2 but not GATA-3 in SH-SY5Y cells,
and not by either GATA factor in HeLa cells.
Decrease of NGB expression upon GATA-2 knockdown
To determine the role of GATA factors in NGB gene ex-
pression, shRNA was employed to reduce the expression of
GATA-2 and -3. The ChIP results have shown the binding
of GATA-2 to Element I in vivo. This strongly suggested
the potential involvement of GATA-2 in the function of El-
ement I as a humanNGB gene enhancer. Although no bind-
ing of GATA-3 to Element I was found, GATA-3 is closely
associated with GATA-2 in gene regulation, and they are
able to inter-regulate. GATA-3 knockdown was therefore
also performed to better elucidate the regulatory network
of NGB gene expression.
To ensure that effects on changes in gene expression of the
lentivirus infected cells were independent of the infection
and associated reactions, a non-targeting shRNA targeting
(SHC002) was used as a control. The results showed that
theGATA-2,GATA-3 andNGB levels were not changed by
infection of SH-SY5Y cells with the SHC002 virus (Figure
4A).
The two GATA-2 targeting shRNAs (pLKO-G2a and -
G2b) effectively decreased the GATA-2 mRNA levels to
30% and 13% of the control level. Interestingly, the NGB
levels of the GATA-2 knockdown cells were also lowered to
35% and 53% of the control level (Figure 4A). This clearly
demonstrated the correlation between GATA-2 and NGB
expression in SH-SY5Y cells. GATA-3 levels in the GATA-
2 knockdown cells also decreased to 58% and 69% of the
control level, although the change was not statistically sig-
nificant. The similar changes in gene expression pattern ob-
served with the two different GATA-2 targeting shRNAs
implies that these were not caused by off-target effects of
the shRNAs (Figure 5).
Similarly, the two GATA-3 targeting shRNAs (pLKO-
G3a and -G3b) significantly lowered GATA-3 mRNA lev-
els to about 17% and 39% of the control level. Surprisingly,
the drop in GATA-3 level was associated with an increase
of GATA-2 and NGB expression. GATA-2 expression in-
creased to 206% and 329% of the control level. NGB ex-
pression increased to 139% in pLKO-G3a infected cells and
about 224% in pLKO-G3b infected cells. These associations
are likely caused by the cross-regulation of GATA-3 and
GATA-2, but the exact mechanism is still unknown.
In Figure 4B, the protein levels of GATA-2, GATA-3,
NGB and -actin are shown. GATA-2 expression dropped
dramatically in SH-SY5Y cells infected with pLKO-G2a
and pLKO-G2b. We noted that the two shRNAs also
mildly decreased the expression of GATA-3. For pLKO-
G3a and pLKO-G3b infected cells, GATA-3 expression
was suppressed while the GATA-2 level was mildly raised.
The control shRNA SHC002 showed no effect on all the
proteins tested. Interestingly, the NGB protein level was
decreased by GATA-2 knockdown, whilst increased by
GATA-3 knockdown. The results imply the importance of
GATA-2 in activating NGB expression.
Deletion of element I reduces NGB gene expression
The regulatory roles of Element I and GATA-2 were
demonstrated by the luciferase reporter and knockdown
experiments respectively. To further illustrate the impor-
tance of Element I in inducing expression of the NGB
gene, Element I was deleted from SH-SY5Y cells by the
CRISPR/Cas9 system. Element I was targeted by two dif-
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Figure 4. (A) The mRNA level of GATA-2, GATA-3 and NGB upon
GATA factor knockdown. cDNA was synthesized from total RNA ex-
tracted from untreated SH-SY5Y cells (Control), and cells infected with
control shRNA vector (SHC002) or GATA-2 (pLKO-G2a and pLKO-
G2b) or GATA-3 (pLKO-G3a and pLKO-G3b) targeting shRNA con-
structs. The amount of mRNA is normalized to -actin level, and ex-
pressed relative to the level in control SH-SY5Y cells. *P < 0.05, **P <
0.01, ***P < 0.001 compared to SHC002 SH-SY5Y cells (N = 3, mean ±
SEM). (B)Western blot analyses of GATA-2 and -3 knockdown SH-SY5Y
cells. Proteins were extracted fromuntreated SH-SY5Y cells (Control), and
cells infected with control shRNA vector (SHC002) or GATA-2 (pLKO-
G2a and pLKO-G2b) or GATA-3 (pLKO-G3a and pLKO-G3b) targeting
shRNA constructs. Bands shown are from three different membranes (one
for control and SHC002, one for pLKO-G2a and b, and one for pLKO-
G3a and b). The amount of protein loaded and exposure times were kept
constant for each membrane. (C) mRNA level of NGB in SH-SY5Y cells
ferent pairs of gRNAs; both gRNA pairs efficiently deleted
the region overlapping Element I (Supplementary Figure
S3A). We found that deletion of Element I significantly de-
creasedNGB expression levels to 13–25% of those observed
in control SH-SY5Y cells (Figure 4C). The expression lev-
els of the intervening genes TMED8 and GSTZ1 were also
decreased but to a lesser extent than the reduction observed
for the NGB gene (Supplementary Figure S4). Collectively,
these results provide strong evidence for the role of Element
I in regulating NGB gene expression.
DISCUSSION
Extensive studies have revealed the structure, evolution, lig-
and binding properties and diverse functions of NGB. To
date, little is known about the control of transcription of the
NGB gene and its possible long-range regulatory elements.
The Locus Control Region (LCR) of the HBB gene clus-
ter comprises distal regulatory elements that activate the
linked -like globin genes by looping and interacting with
their promoters to form an Active Chromatin Hub (ACH)
(10,46,47). Recently, Dekker et al. (11) showed that a 3C-
based approach could identify novel distal regulatory el-
ements of the cystic fibrosis transmembrane conductance
regulator gene (CFTR).
Here, with a similar approach we identified two novel el-
ements within the 300 kb region around the locus of the
NGB gene. The results of the 3C experiments demonstrated
that these elements are located at around −70 kb upstream
and +100 kb downstream of the NGB gene TSS. Thus, we
identified the presence of potential long-range regulatory el-
ements of the human NGB gene.
The DRE located−70 kb upstream of theNGB gene (El-
ement I) specifically interacts with and transactivates the
NGB gene promoter in neuronal cells. An active chromatin
loop is likely formed between Element I and the NGB pro-
moter upon neuronal differentiation which drives the ex-
pression of NGB gene. The interaction frequency of such
looping is higher in SH-SY5Y cells than in HeLa cells (Fig-
ure 1B andC). It has been suggested that the interaction fre-
quency may represent the ‘strength’ of the looping (48), im-
plying Element I is fully functional in activating NGB tran-
scription with the ‘strong’ looping observed in SH-SY5Y
cells.
The GATA-2 transcription factor was shown to bind to
Element I. GATA factors are known to be important in
establishing and maintaining chromatin looping (48–51).
Such looping can be transcriptionally activating or repres-
sive, as demonstrated by the interplay of GATA-1 and -2 in
the regulation of theKIT gene. The binding and function of
the GATA factors are cell differentiation status dependent
(49) and locus dependent (48). Our results demonstrated
that GATA-2 knockdown was associated with suppression
of NGB gene expression. Developmental studies suggest
that bothGATA-2 (40) andNGB (52) are expressed early in
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
with and without Element I deletion. Del-A and -B are cells with Element I
deleted by different gRNA pairs. The levels are normalized to -actin level
and expressed relative to the level in control SH-SY5Y cells. *P < 0.05,
**P < 0.01 compared to control SH-SY5Y cells (N = 3, mean ± SEM).
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Figure 5. Microarray analysis of GATA-2 and NGB expression level in
different parts of the brain (Image credit: Allen Institute (53)). Associ-
ated expression of the two genes is shown in dorsal and ventral thalamus,
mesencephalon, pontine tegmentum and myelencephalon. Red and green
on the heat map represent high and low expression respectively. For each
structure, six samples are displayed.
the course of neurogenesis. Searches in the Allen Brain At-
las (53) (http://human.brain-map.org) revealed that NGB
and GATA-2 co-express in parts of the brain including
the dorsal and ventral thalamus, mesencephalon, pontine
tegmentum and myelencephalon. The expression level of
the two genes are not always associated. This implies ad-
ditional factors are responsible for the control ofNGB gene
expression. In retina, GATA-2 is expressed and governs
VEGF receptor 2 expression (54). VEGF has been found
to stimulate NGB expression (55). Thus, the expression of
GATA-2 may have an additive effect on upregulating NGB
expression by (a) stabilizing chromatin looping between El-
ement I and the NGB promoter and (b) enhancing the ef-
fects of VEGF by increasing VEGF receptors on the cells.
This may explain why the highest level of NGB is found in
the retina.
Knockdown of GATA-2 caused a reduction in in NGB
and GATA-3 expression. In contrast, GATA-3 knockdown
led to an increase in NGB and GATA-2 expression. This
phenomenon could be attributed to the genetic interac-
tions between GATA-2 and GATA-3 during central ner-
vous system development, as GATA-3 expression is GATA-
2-dependent (40). In trophoblast cells, GATA-3 acts as a
negative regulator of the GATA-2 gene by occupying distal
regulatory sites. Upon trophoblast differentiation, GATA-
3 is displaced by GATA-2 and GATA-2 gene transcription
is activated (56). In SH-SY5Y cells with GATA-3 knock-
down, the suppression was probably relieved thus GATA-
2 expression increased. Therefore, there may be two possi-
ble ways by which GATA-3 regulatesNGB transcription: a)
GATA-3 may compete with GATA-2 for the GATA sites
within Element I to affect the function of the chromatin
loop; b) Expression of GATA-3 limits the level of GATA-2
which is the trans activator for NGB gene transcription.
Interestingly, GATA-2 has been shown to cooperate with
Sp1 to activate gene expression (57–59). Zhang et al. (12)
previously demonstrated that Sp1 and Sp3 bind to and reg-
ulate the promoter of human NGB gene. Overexpression of
Sp1 and/or Sp3 in SH-SY5Y cells significantly increased
NGB promoter activity. The study also identified the role
of DNA methylation in controlling the expression of NGB.
Taken together, we propose that GATA-2 bound to the dis-
tal Element I may be brought to close proximity of the
NGB promoter through interaction with Sp1 bound on the
promoter to transactivate the transcriptional activation of
NGB (Figure 6A). In cells that do not express NGB, the
promoter is hypermethylated (data not shown). This may
block the binding of Sp factors and prevent the GATA fac-
tors from the distal element from interacting productively
with the promoter of the NGB gene (Figure 6B).
In addition to GATA factors, other TFs shown in the
ENCODE database may contribute to the differences of the
interaction frequencies between Element I and NGB gene.
These include Corepressor for element-1-silencing tran-
scription factor (CoREST) present in Element I in K562
andHeLa S3 andNeuron-restrictive silencer factor (NRSF)
detected in K562. NRSF and CoREST are only expressed
in non-neuronal cells and are involved in chromatin remod-
eling, in particularwith respect to silencing of neuronal gene
expression (60,61). These TFs might modify the chromatin
structure around Element I in HeLa and other non-NGB
expressing cells to a state which hinders the formation of an
activating chromatin loop, thus decreasing the interaction
frequency between the distal Element I and the NGB gene
promoter. This provides an explanation for the suppression
of NGB expression in K562 and Hela cells.
The luciferase reporter assays revealed the cell type-
specific enhancer function of Element I in SH-SY5Y cells.
However, the enhancer function was surprisingly position-
and orientation-dependent, which deviates from the classi-
cal definition of enhancers which are elements activating
transcription in a position- and orientation-independent
manner. Although orientation-dependent enhancers are
rare, they have been previously reported such as the en-
hancers of CCL2 (62), PROP1 (63), Pro1(I) collagen (64)
and Shsp/B-crytallin (65). The orientation-dependence
phenomenon was also observed in the HBB LCR. It was
shown that the expression of the HBB gene was reduced
when the orientation of the LCR was changed or the or-
der of the genes in the gene cluster was altered (66). Thus
to achieve the copy number- and position-independent ex-
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Figure 6. Schematic diagrams illustrating the function of Element I in NGB gene transcription regulation. (A) In NGB-expressing cells, a chromatin loop
is formed between the NGB promoter and Element I. The loop brings GATA-2 on Element I and Sp1 on the hypomethylatedNGB promoter (open circle)
in close proximity and activates transcription. (B) In cells not expressingNGB, the promoter ofNGB gene is hypermethylated (filled circles) and binding of
Sp1 and Sp3 is inhibited. This impairs the interaction between the promoter and Element I. The formation of looping may also be affected by competition
between GATA-2 and -3 for the binding sites within Element I.
pression of the HBB gene, the intact gene and the LCR
must be integrated into the genome. Themechanism behind
the orientation dependence is unclear. It was suggested that
the orientation independence of enhancers would only be
achieved when all the necessary transcription factor bind-
ing sites are present in the right order and location so
that the transcription factors can be assembled to confer
the activating function in full (5,67). Thus the orientation-
and position-independence are only valid when viewing
the enhancer on the whole. The enhancers found to be
orientation- and position-dependent may lack some of the
transcription factor binding sites. Amore extensive analysis
which covers larger regions surrounding Elements I and II
will be required to address this issue.
The role of Element I in activating NGB expression was
supported by the CRISPR-mediated deletion. However, we
found that the expression of the intervening genes TMED8,
GSTZ1 and POMT2 were also affected. Since our 3C data
showed that Element I also interacts with the promoter re-
gions of the intervening genes, it is reasonable to assume
that Element I controls more than one gene. The effect of
Element I deletion on expression of the intervening genes
was the greatest on TMED8, of which expression was de-
creased to 35–66% of the wild type level. Since the region
deleted was within an intron of this gene, deletion of Ele-
ment I may affect pre-mRNA stability and/or splicing of
TMED8 RNA. Remarkably, expression of the NGB gene
was more strongly reduced upon deletion of Element I. It
has been observed that enhancers are most likely to acti-
vate the nearest gene (1). Despite the closer proximity of
the TMED8, GSTZ1 and POMT2 promoters to Element I,
our data indicate that the interactions between Element I
and the NGB promoter are favored in neuronal SH-SY5Y
cells. We surmise that these favorable interactions are de-
pendent on the particular combination of transcription fac-
tors bound at Element I and the NGB promoter in SH-
SY5Y cells.
In conclusion, our data show that the -70kb Element I
interacts via a looping mechanism with the NGB promoter
to activate and confer cell-specific NGB gene expression.
GATA-2 is one of the transcription factors governing the
activation of NGB gene expression. Such information will
contribute to understanding the physiological and patho-
logical roles of NGB, and to further explore its potential
therapeutic and disease-preventing properties in neurologi-
cal conditions such as Alzheimer’s disease.
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